Nuclear medicine camera vendor Trionix will forgo exhibiting atthis year's Radiological Society of North America conference infavor of more specialized nuclear medicine meetings. The Twinsburg,OH-based company, known for its towering exhibit booth, has
Nuclear medicine camera vendor Trionix will forgo exhibiting atthis year's Radiological Society of North America conference infavor of more specialized nuclear medicine meetings. The Twinsburg,OH-based company, known for its towering exhibit booth, has decidedthat the expense and disruption of attending both the RSNA meetingin November and a European nuclear medicine meeting in Octoberwould put too much of a strain on corporate resources, accordingto president Chun Bin Lim.
Trionix introduced an upgrade to its Triad and Biad line ofgamma cameras at the Society of Nuclear Medicine in Toronto inJune. The company has decided to concentrate on refining the linerather than spend time moving exhibit booths and products aroundthe world, Lim said.
"When you go to a show, it tends to disrupt the entireorganization," Lim said. "Because of that, this yearwe decided not to go to the RSNA."
Instead, Trionix will head to the European Association of NuclearMedicine meeting in Lucerne, Switzerland in October. Trionix isparticipating heavily in that show and its exhibit booth willbe the largest at the meeting, Lim said.
Trionix's preference for the European show is both a sign ofthe company's growing emphasis on international sales, as wellas its desire to make the most of its marketing dollar by attendingmore focused conferences. The RSNA meeting's gargantuan size--andits inclusion of all radiology modalities--can be frustratingfor a single-modality vendor like Trionix.
"I'm not saying anything negative about RSNA. (Marketingto) radiology is just not very effective in getting our pointsacross," Lim said. "There are simply too many peopleand too many products."
Trionix's new product line includes the Triad XLT and BiadXLT, and the Biad Slimline, designed for siting in small rooms.Trionix conducted a promotional tour of Europe and Australia insupport of the products. The cameras, which have Food and DrugAdministration marketing clearance, are undergoing clinical validationprior to marketing.
Trionix is not concerned that its absence from the RSNA meetingwill generate rumors about the company's viability. Orders areup 80% over last year and the company is growing, according toLim.
"I don't worry about that kind of thing," Lim saidof market gossip. "Since the beginning of the company it'sbeen our policy not to pay attention to what other people say,particularly competitors."
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.